| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.007 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.006 |